Evolus (EOLS) Non-Current Assets (2017 - 2026)
Evolus (EOLS) reported Non-Current Assets of $81.7 million for Q1 2026, little changed on a YoY basis from $81.6 million in Q1 2025, and down 1.48% quarter-over-quarter from $83.0 million in Q4 2025.
Evolus (EOLS) Non-Current Assets (2017 - 2026) Analysis & Trends
Evolus has reported Non-Current Assets for 10 years, with the latest figure at $81.7 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets changed 0.1% year-over-year to $81.7 million; the trailing twelve-month figure through Mar 2026 stood at $332.6 million (up 4.68% YoY), and the FY2025 full-year result was $83.0 million, up 2.12% from the prior year.
- Non-Current Assets for Q1 2026 stood at $81.7 million, down from $83.0 million in the prior quarter.
- The five-year high for Non-Current Assets was $84.1 million in Q3 2025, with the low at $72.5 million in Q2 2023.
- Historically, Non-Current Assets has averaged $78.6 million across 5 years, with a median of $77.2 million in 2022.
- Annual changes were most pronounced in 2023 — Non-Current Assets dropped 5.78% — and 2025, when it grew 10.83%.
- Evolus' Non-Current Assets stood at $77.2 million in 2022, then dropped by 0.78% to $76.6 million in 2023, then grew by 6.07% to $81.2 million in 2024, then grew by 2.12% to $83.0 million in 2025, then dropped by 1.48% to $81.7 million in 2026.
- The last three Non-Current Assets figures came in at $81.7 million (Q1 2026), $83.0 million (Q4 2025), and $84.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.40 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.22 Bn |
| 10 | Evolus | 435.45 Mn | 385.65 Mn | 48.90 Mn | 81.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.72 Mn |
| Dec 31, 2025 | 82.95 Mn |
| Sep 30, 2025 | 84.11 Mn |
| Jun 30, 2025 | 83.83 Mn |
| Mar 31, 2025 | 81.64 Mn |
| Dec 31, 2024 | 81.23 Mn |
| Sep 30, 2024 | 79.25 Mn |
| Jun 30, 2024 | 75.64 Mn |
| Mar 31, 2024 | 75.91 Mn |
| Dec 31, 2023 | 76.58 Mn |
| Sep 30, 2023 | 75.97 Mn |
| Jun 30, 2023 | 72.52 Mn |
| Mar 31, 2023 | 76.15 Mn |
| Dec 31, 2022 | 77.18 Mn |
| Sep 30, 2022 | 76.77 Mn |
| Jun 30, 2022 | 76.97 Mn |
| Mar 31, 2022 | 77.73 Mn |
| Dec 31, 2021 | 78.68 Mn |
| Sep 30, 2021 | 76.88 Mn |
| Jun 30, 2021 | 77.97 Mn |